Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Recurrent CUD in patients with a prior history of CUD was defined as a medical encounter for CUD diagnosis (ICD-10 F12) after the index event
Chemical & Handling Information Type: Synthetic GLP-1 analog (long-acting) Backbone: Modified human GLP-1 peptide with fatty-acid side chain for albumin binding and prolonged half-life (exact modification per specification/lot) Appearance: White to off-white lyophilized powder Specifications Peptide: Semaglutide Amount: 10 mg per vial Form: Lyophilized powder Purity: 99% (HPLC)
Since this is a compounded formulation and not an FDA-approved combination, seeking professional consultation is essential
C., & Garzn, I
US$ 21.08
US$ 28.62
US$ 28.16
US$ 22.93
US$ 29.46
US$ 24.50
US$ 28.82
US$ 24.35
